History of biological warfare and bioterrorism.

Bioterrorism literally means using microorganisms or infected samples to cause terror and panic in populations. Bioterrorism had already started 14 centuries before Christ, when the Hittites sent infected rams to their enemies. However, apart from some rare well-documented events, it is often very difficult for historians and microbiologists to differentiate natural epidemics from alleged biological attacks, because: (i) little information is available for times before the advent of modern microbiology; (ii) truth may be manipulated for political reasons, especially for a hot topic such as a biological attack; and (iii) the passage of time may also have distorted the reality of the past. Nevertheless, we have tried to provide to clinical microbiologists an overview of some likely biological warfare that occurred before the 18th century and that included the intentional spread of epidemic diseases such as tularaemia, plague, malaria, smallpox, yellow fever, and leprosy. We also summarize the main events that occurred during the modern microbiology era, from World War I to the recent 'anthrax letters' that followed the World Trade Center attack of September 2001. Again, the political polemic surrounding the use of infectious agents as a weapon may distort the truth. This is nicely exemplified by the Sverdlovsk accident, which was initially attributed by the authorities to a natural foodborne outbreak, and was officially recognized as having a military cause only 13 years later.

Étude éco-épidémiologique sur l’infection par Francisella tularensis au Québec

Au Canada, Francisella tularensis, une bactérie zoonotique causant la tularémie, affecte principalement le lièvre d’Amérique, le rat musqué et le castor. Malgré les nombreuses études sur cette maladie, les connaissances sur l’écologie et les réservoirs naturels de la tularémie demeurent limitées. Une étude transversale a été réalisée afin d’estimer la prévalence d’infection par F. tularensis chez le lièvre d’Amérique, le rat musqué et le coyote dans quatre régions du Québec (Canada) et de décrire le risque d’infection d’après des caractéristiques individuelles (âge, sexe et état de chair) et environnementales. D’octobre 2012 à avril 2013, 345 lièvres d’Amérique, 411 rats musqués et 385 coyotes capturés par des trappeurs ont été échantillonnés. Les caractéristiques environnementales autour du site de capture ont été extraites de base de données géographiques. La séroprévalence (test de microagglutination) était de 2.9% chez les coyotes, 0.6% chez les lièvres et 0% chez les rats musqués. Tous les rats musqués et les lièvres étaient négatifs à une PCR en temps réel réalisée à partir d’un pool de foie, rein, rate et poumon; par contre, le type AI a été détecté dans les organes individuels des deux lièvres séropositifs. Des analyses de régression logistique exacte ont démontré que l’âge était un facteur de risque pour la séropositivité du coyote, ainsi que la proportion de forêts et la proportion de l’environnement considéré approprié pour le lièvre autour de la localisation de capture des coyotes. Les résultats de cette étude suggèrent la présence du cycle terrestre dans les régions étudiées.

Rapid diagnosis and quantification of Francisella tularensis in organs of naturally infected common squirrel monkeys (Saimiri sciureus)

Francisella tularensis, a small Gram-negative facultative intracellular bacterium, is the causative agent of tularaemia, a severe zoonotic disease transmitted to humans mostly by vectors such as ticks, flies and mosquitoes. The disease is endemic in many parts of the northern hemisphere. Among animals, the most affected species belong to rodents and lagomorphs, in particular hares. However, in the recent years, many cases of tularaemia among small monkeys in zoos were reported. We have developed a real-time PCR that allows to quantify F. tularensis in tissue samples. Using this method, we identified the spleen and the kidney as the most heavily infected organ containing up to 400 F. tularensis bacteria per simian host cell in two common squirrel monkeys (Saimiri sciureus) from a zoo that died of tularaemia. In other organs such as the brain, F. tularensis was detected at much lower titres. The strain that caused the infection was identified as F. tularensis subsp. holarctica biovar I, which is susceptible to erythromycin. The high number of F. tularensis present in soft organs such as spleen, liver and kidney represents a high risk for persons handling such carcasses and explains the transmission of the disease to a pathologist during post-mortem analysis. Herein, we show that real-time PCR allows a reliable and rapid diagnosis of F. tularensis directly from tissue samples of infected animals, which is crucial in order to attempt accurate prophylactic measures, especially in cases where humans or other animals have been exposed to this highly contagious pathogen.

Characterisation of a new group of Francisella tularensis subsp. holarctica in Switzerland with altered antimicrobial susceptibilities, 1996 to 2013

Molecular analysis of Francisella tularensis subsp. holarctica isolates from humans and animals revealed the presence of two subgroups belonging to the phylogenetic groups B.FTNF002-00 and B.13 in Switzerland. This finding suggests a broader spread of this group in Europe than previously reported. Until recently, only strains belonging to the Western European cluster (group B.FTNF002-00) had been isolated from tularaemia cases in Switzerland. The endemic strains belonging to group B.FTNF002-00 are sensitive to erythromycin, in contrast to the strains of the newly detected group B.13 that are resistant to this antibiotic. All the strains tested were susceptible to ciprofloxacin, streptomycin, gentamicin, nalidixic acid and chloramphenicol but showed reduced susceptibility to tetracycline when tested in a growth medium supplemented with divalent cations. The data show a previously undetected spread of group B.13 westwards in Europe, associated with changes in the antibiotic resistance profile relevant to treatment of tularaemia.